The forecasted mortality data for chronic liver diseases and cirrhosis among males in the UK indicates a steady increase from 2024 to 2028, starting at 6.2 thousand deaths in 2024 and rising to 6.75 thousand by 2028. The annual growth rate reveals a consistent upward trajectory, with year-on-year increases evident across the forecast period. Notably, from 2023 to 2024, the rate is projected to rise from an estimated base level, signaling an ongoing trend.
The five-year compound annual growth rate (CAGR) highlights an average annual increase, underscoring a persistent upward movement in mortality rates over this period.
Future trends to watch for include:
- The impact of public health interventions targeting liver health.
- Shifts in healthcare policies aimed at reducing liver disease risk factors.
- Socioeconomic factors influencing healthcare access and lifestyle changes.
